Handelsbanken Fonder’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Hold |
43,211
| – | – | 0.01% | 721 |
|
|
2025
Q1 | $1.3M | Sell |
43,211
-600
| -1% | -$18.1K | 0.01% | 831 |
|
|
2024
Q4 | $1.53M | Buy |
43,811
+800
| +2% | +$28K | 0.01% | 780 |
|
|
2024
Q3 | $1.72M | Buy |
43,011
+9,100
| +27% | +$365K | 0.01% | 717 |
|
|
2024
Q2 | $1.62M | Hold |
33,911
| – | – | 0.01% | 650 |
|
|
2024
Q1 | $1.47M | Buy |
33,911
+6,900
| +26% | +$299K | 0.01% | 691 |
|
|
2023
Q4 | $1.37M | Buy |
27,011
+3,200
| +13% | +$162K | 0.01% | 675 |
|
|
2023
Q3 | $1.08M | Sell |
23,811
-6,900
| -22% | -$313K | 0.01% | 695 |
|
|
2023
Q2 | $1.26M | Buy |
30,711
+12,200
| +66% | +$501K | 0.01% | 655 |
|
|
2023
Q1 | $662K | Hold |
18,511
| – | – | ﹤0.01% | 868 |
|
|
2022
Q4 | $699K | Hold |
18,511
| – | – | ﹤0.01% | 782 |
|
|
2022
Q3 | $819K | Hold |
18,511
| – | – | 0.01% | 728 |
|
|
2022
Q2 | $685K | Buy |
18,511
+4,800
| +35% | +$178K | ﹤0.01% | 832 |
|
|
2022
Q1 | $508K | Sell |
13,711
-10,700
| -44% | -$396K | ﹤0.01% | 1202 |
|
|
2021
Q4 | $743K | Hold |
24,411
| – | – | ﹤0.01% | 1079 |
|
|
2021
Q3 | $819K | Hold |
24,411
| – | – | ﹤0.01% | 1026 |
|
|
2021
Q2 | $974K | Buy |
24,411
+1,400
| +6% | +$55.9K | 0.01% | 937 |
|
|
2021
Q1 | $1.04M | Sell |
23,011
-3,600
| -14% | -$162K | 0.01% | 826 |
|
|
2020
Q4 | $1.51M | Buy |
26,611
+4,300
| +19% | +$243K | 0.01% | 678 |
|
|
2020
Q3 | $1.06M | Hold |
22,311
| – | – | 0.01% | 708 |
|
|
2020
Q2 | $1.32M | Buy |
+22,311
| New | +$1.32M | 0.01% | 612 |
|